Art Therapy in Progressive Supranuclear Palsy

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Final enrollment: 19 participants (planned 10) Show 4 more changesShow less
    • Secondary endpoints: details revised at 3 of 3 entries
    • Collaborators: 1 to 2
    • Publications: details revised at 4 of 4 entries
    • Eligibility criteria expanded, about 4 words
  2. Study completion pushed from Dec 2, 2026 to Jul 2, 2027v6
  3. Collaborator revisedv5
  4. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Sep 2, 2025 to Dec 31, 2025
    • Study completion date: Sep 2, 2026 to Dec 2, 2026
    • Site details revised
    v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 2025 to Jan 14, 2025
    v3
  6. Start date: Oct 2, 2024 to Jan 2025v2
  7. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Our aim is to study the effect of art therapy for people with PSP, with a focus on alleviating the symptoms associated with PSP, enhancing the overall quality of life for patients, and reducing caregiver stress. Overall, through our collaborative efforts on this study, we hope to unlock the benefits of art therapy for this vulnerable patient population, ultimately improving their overall well-being and enhancing their quality of life.
Trial Details
NCT Number NCT06588673
Lead Sponsor Vanderbilt University Medical Center
Collaborators: CurePSP Foundation, Baylor University
Conditions
(from sponsor)		 Progressive Supranuclear Palsy
Related terms Supranuclear Palsy, Progressive
Enrollment 19 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov